Found: 15
Select item for more details and to access through your institution.
Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH).
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0298026
- By:
- Publication type:
- Article
Concise Review: The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia.
- Published in:
- Stem Cells, 2012, v. 30, n. 8, p. 1581, doi. 10.1002/stem.1140
- By:
- Publication type:
- Article
Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 318, doi. 10.1111/bjh.16336
- By:
- Publication type:
- Article
Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 229, doi. 10.1002/ajh.26768
- By:
- Publication type:
- Article
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38113-4
- By:
- Publication type:
- Article
Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00181
- By:
- Publication type:
- Article
Patient‐reported symptom burden and impact on daily activities in chronic graft‐versus‐host disease.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3623, doi. 10.1002/cam4.5209
- By:
- Publication type:
- Article
Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 8, p. 1027, doi. 10.1007/s11864-024-01240-1
- By:
- Publication type:
- Article
Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 144, doi. 10.1002/ajh.23882
- By:
- Publication type:
- Article
Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 952, doi. 10.1634/theoncologist.2015-0108
- By:
- Publication type:
- Article
Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 10, p. 1826, doi. 10.1002/cncr.35189
- By:
- Publication type:
- Article
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 451, doi. 10.1007/s40487-024-00288-1
- By:
- Publication type:
- Article